Source comparison
Using BPC-157 for Wound Healing Research Evidence: Type Comparison
Full-thickness excisional wound (rodent) Wound area reduction 10 mcg/kg IP daily 60–80% faster closure by day 7 VEGF upregulation, angiogenesis, collagen deposition Most robust evidence. Multiple independent replications show consistent effect Incisional wound
This comparison does not assign a generated winner or score.
- Full-thickness excisional wound (rodent)
- Wound area reduction
- 10 mcg/kg IP daily
- 60–80% faster closure by day 7
- VEGF upregulation, angiogenesis, collagen deposition
- Most robust evidence. Multiple independent replications show consistent effect
- Incisional wound with sutures (rodent)
- Tensile strength at 14 days
- 10 mcg/kg–10 mg/kg IP
- 40–60% higher breaking force
- Enhanced collagen crosslinking, fibroblast migration
- Mechanical integrity confirmed. Not just surface closure
- Gastric ulcer model (rodent)
- Ulcer area reduction, histology
- 10 mcg/kg IP or oral
- 50–70% reduction in ulcer size by day 7
- Mucosal protection, NO pathway stabilization
- Demonstrates systemic effect beyond topical application
- Topical application (rodent skin wound)
- Epithelialization rate
- 0.1–1.0 mg/mL applied daily
- Accelerated re-epithelialization by day 5
- Direct growth factor signaling at wound bed
- Shows local efficacy. Useful for surface wounds
- Diabetic wound model
- Not studied
- N/A
- Critical gap. Most clinically relevant population unstudied
- Human clinical trial
- Not conducted
- Zero human data. All extrapolation is speculative